Fischer Medical Ventures
Fischer Medical Ventures Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Fischer Medical Ventures Limited, framed against the sector median so the premium or discount is obvious at a glance.
Fischer Medical Ventures Limited trades at a P/E of 74.57× and P/B of 5.97×.
Valuation
Profitability
Growth
Financial Health
Fischer Medical Ventures Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Fischer Medical Ventures Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Fischer Medical Ventures Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Fischer Medical Ventures Limited, switchable between annual and quarterly views, consolidated or standalone.
Fischer Medical Ventures Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹23,64,76,43,931.1 Cr and reported EPS of ₹0.45.
| Period | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue from Operations | 21 | 111 | 309 |
| Other Income | 1 | 1 | 12 |
| Total Income | 21 | 112 | 321 |
| Cost of Goods Sold (COGS) | 16 | 92 | 143 |
| Gross Profit | 5 | 19 | 166 |
| +Operating Expenses | 3 | 16 | 123 |
| EBITDA | 2 | 3 | 43 |
| +Non-Operating Expenses | 0 | 2 | 9 |
| Profit Before Tax (PBT) | 2 | 2 | 47 |
| +Tax Expense | 0 | 1 | 15 |
| Total Profit for Period | 2 | 1 | 31 |
| Less: Non-controlling Interests | — | -0 | — |
| Net Profit (Owner's PAT) | 2 | 1 | 31 |
| Earnings Per Share (EPS) | 0.03 | 0.02 | 0.47 |
| Diluted Shares Outstanding (Nos.) | 54 | 64 | 65 |
| +Additional Disclosures | 36 | 201 | 417 |
| Sales Growth % | — | 427.61 | 178.75 |
| YoY Sales Growth % | — | 427.61 | 178.75 |
| Material Cost % | 75 | — | 20 |
| Employee Cost % | 2 | 2 | 5 |
| Other Cost % | 11 | 12 | 35 |
| OPM % | 9 | 3 | 14 |
| Tax % | 13 | 46 | 33 |
| Profit Growth % | — | -19.39 | 1,993.64 |
| Gross Margin % | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 |
| +Additional Fields | 2 | 2 | 40 |
Fischer Medical Ventures segment analysis: revenue and profit mix.
Disclosed business segments at Fischer Medical Ventures with their share of revenue and profit, switchable between consolidated and standalone reporting.
Fischer Medical Ventures discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Fischer Medical Ventures Limited.
Our AI distills the core fundamental drivers supporting Fischer Medical Ventures Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Fischer Medical Ventures Limited's investment case rests on 8 positive markers and 8 flagged concerns drawn from the latest reported filings.
What you're getting.
The company reported a phenomenal 2928% increase in quarterly profit, reaching 13.9 Cr, indicating a strong recent turnaround in profitability. This significant surge suggests improving operational efficiency and demand.
Fischer Medical Ventures demonstrated impressive quarterly sales growth of 118%, with sales reaching 86.3 Cr. This strong top-line expansion highlights increasing market penetration and product acceptance.
Promoter holding stands at a substantial 61.8%, reflecting strong confidence from the management in the company's future prospects and long-term value creation. This provides stability.
With a debt-to-equity ratio of 0.25, the company maintains a very healthy balance sheet, indicating low financial risk and ample room for future expansion or capital expenditure without excessive leverage.
Operating in the "Medical Equipment & Supplies" industry within the "Healthcare" sector, Fischer is poised to benefit from increasing healthcare expenditure, technological advancements, and rising demand for medical devices.
What can break it.
The company's P/E ratio of 372.00 is exceptionally high compared to the industry average and peers, suggesting the stock might be significantly overvalued relative to its current earnings. This poses a valuation risk.
Fischer's ROE at 0.70% and ROCE at 1.08% are very low, indicating inefficient utilization of shareholder funds and capital. These metrics are significantly below industry benchmarks.
The stock is trading at 115.00, substantially below its 52-week high of 1194.40, indicating significant price volatility and a substantial value erosion for long-term holders.
The company has a 0.00% dividend yield, meaning it does not currently distribute profits to shareholders. This might deter income-focused investors seeking regular returns from their investments.
The "Medical Equipment & Supplies" industry is highly competitive, with numerous domestic and international players. This intense competition could pressure pricing and market share, impacting profitability.
What would change my mind.
Trim if P/E re-rates above 97. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Fischer Medical Ventures Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Fischer Medical Ventures Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
Fischer Medical Ventures Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Fischer Medical Ventures Limited — derived from the live tape, not yesterday's close.
Fischer Medical Ventures Limited last traded at ₹36.13 with an intraday range of ₹34.66–₹36.6 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹36.13| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 40.81 | +4.68 | +12.96% |
| R3 | 38.87 | +2.74 | +7.59% |
| R2 | 37.74 | +1.61 | +4.45% |
| R1 | 36.93 | +0.80 | +2.22% |
| PIVOT | 35.80 | -0.33 | -0.92% |
| CURRENT | 36.13 | — | — |
| S1 | 31.11 | -5.02 | -13.89% |
| S2 | 33.05 | -3.08 | -8.52% |
| S3 | 33.86 | -2.27 | -6.29% |
| S4 | 34.99 | -1.14 | -3.15% |
FISCHER is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 34.66 ~ 35.45
Trading Above opening range, showing Bullishness
Fischer Medical Ventures Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Fischer Medical Ventures Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Fischer Medical Ventures Limited stood at 36.0% of traded volume, against a 20-day average of 36.6%.
Fischer Medical Ventures announcements: results, concalls, ratings, M&A.
Filings Fischer Medical Ventures sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Fischer Medical Ventures files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 81 documents below.
Outcome of Board Meeting
Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Copy of Newspaper Publication
Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
Press Release
Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Press Release on Landmark…
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Fischer Medical Ventures Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Disclosure under SEBI Takeover Regulations
SHANKAR VARADHARAJAN has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Fischer Medical Ventures insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Fischer Medical Ventures as reported to SEBI — buying and selling signals from the people who know the business best.
Fischer Medical Ventures insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr | ₹23.40 |
Fischer Medical Ventures dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Fischer Medical Ventures has declared, sequenced by announce and record date.
Fischer Medical Ventures corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Fischer Medical Ventures Limited: business, sector, key facts.
What Fischer Medical Ventures Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Fischer Medical Ventures Limited operates in the Medical Equipment & Supplies industry under the Healthcare sector, listed as NSE: FISCHER, BSE: 524743.
Questions investors ask about Fischer Medical Ventures Limited (FISCHER).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Fischer Medical Ventures Limited (FISCHER)?
The current share price of Fischer Medical Ventures Limited (FISCHER) is ₹36.13. Today, the stock has gained by ₹0.97 (2.76%), trading in a range of ₹34.66 to ₹36.6. The stock opened at ₹35.23 with a trading volume of 11,34,515 shares.
02Is Fischer Medical Ventures Limited stock a good investment for long-term?
Fischer Medical Ventures Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹23,64,76,43,931.1 crores, P/E ratio of 74.57, ROE of 8.63%, and ROCE of 1.08%. The dividend yield stands at 0.01%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Fischer Medical Ventures Limited stock?
The 52-week high price of Fischer Medical Ventures Limited (FISCHER) is ₹1,194.4, while the 52-week low is ₹31.05. Currently trading at ₹36.13, the stock is 0.4% away from its 52-week low and 97.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Fischer Medical Ventures Limited stock at the current price?
Whether to buy Fischer Medical Ventures Limited stock at ₹36.13 depends on multiple factors. The stock is currently trading with a P/E ratio of 74.57 and P/B ratio of 5.97. Today's performance shows a gain of 2.76%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Fischer Medical Ventures Limited and when is the next dividend?
Fischer Medical Ventures Limited offers a dividend yield of 0.01%, which means for every ₹100 invested at the current price of ₹36.13, you can expect to receive approximately ₹0.01 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Fischer Medical Ventures Limited?
Fischer Medical Ventures Limited's key financial metrics include: P/E Ratio: 74.57, P/B Ratio: 5.97, ROE: 8.63%, ROCE: 1.08%, Dividend Yield: 0.01%, EPS: ₹0.45, Book Value: ₹5.96, and Debt-to-Equity: 0.28. The company's market cap stands at ₹23,64,76,43,931.1 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Fischer Medical Ventures Limited stock performing today in the market?
Fischer Medical Ventures Limited stock opened at ₹35.23 and is currently trading at ₹36.13, showing a gain of ₹0.97 (2.76%). The intraday high is ₹36.6 and low is ₹34.66. The trading volume stands at 11,34,515 shares, indicating strong market participation today.
08What is the P/E ratio of Fischer Medical Ventures Limited and what does it indicate?
Fischer Medical Ventures Limited has a Price-to-Earnings (P/E) ratio of 74.57, which means investors are willing to pay ₹74.57 for every ₹1 of earnings. With an EPS of ₹0.45, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Fischer Medical Ventures Limited (FISCHER) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy